- Home
- VNDA vs POET Comparison
VNDA vs POET Comparison
Compare VNDA & POET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- POET
- Stock Information
- Founded
- VNDA 2002
- POET 1972
- Country
- VNDA United States
- POET Canada
- Employees
- VNDA N/A
- POET N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- POET Semiconductors
- Sector
- VNDA Health Care
- POET Technology
- Exchange
- VNDA Nasdaq
- POET Nasdaq
- Market Cap
- VNDA 261.7M
- POET 366.1M
- IPO Year
- VNDA 2006
- POET N/A
- Fundamental
- Price
- VNDA $5.02
- POET $5.74
- Analyst Decision
- VNDA Strong Buy
- POET Strong Buy
- Analyst Count
- VNDA 3
- POET 2
- Target Price
- VNDA $15.33
- POET $6.25
- AVG Volume (30 Days)
- VNDA 414.8K
- POET 1.9M
- Earning Date
- VNDA 07-30-2025
- POET 08-13-2025
- Dividend Yield
- VNDA N/A
- POET N/A
- EPS Growth
- VNDA N/A
- POET N/A
- EPS
- VNDA N/A
- POET N/A
- Revenue
- VNDA $201,351,000.00
- POET $199,477.00
- Revenue This Year
- VNDA $16.86
- POET $8,377.56
- Revenue Next Year
- VNDA $39.78
- POET $1,061.73
- P/E Ratio
- VNDA N/A
- POET N/A
- Revenue Growth
- VNDA 13.37
- POET N/A
- 52 Week Low
- VNDA $3.81
- POET $2.27
- 52 Week High
- VNDA $6.37
- POET $7.79
- Technical
- Relative Strength Index (RSI)
- VNDA 67.29
- POET 73.94
- Support Level
- VNDA $4.66
- POET $4.94
- Resistance Level
- VNDA $4.95
- POET $5.94
- Average True Range (ATR)
- VNDA 0.15
- POET 0.39
- MACD
- VNDA 0.03
- POET 0.16
- Stochastic Oscillator
- VNDA 89.39
- POET 87.50
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About POET POET Technologies Inc.
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.